Emmanuel J Favaloro/LinkedIn
Jan 17, 2026, 04:58
Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
Emmanuel J Favaloro, Lead Scientist of Sydney Centres for Thrombosis and Haemostasis, shared on LinkedIn:
“A Review of Desmopressin Use in Bleeding Disorders. Nearly 5000 article views in only 6 months. Aiming for 10,000 by it’s one year anniversary.
Free to download from here .”
Title: A Review of Desmopressin Use in Bleeding Disorders: An Unsung Hero?
Authors: Benjamin Reardon, Leonardo Pasalic, Emmanuel J. Favaloro
Find more posts featuring Emmanuel J Favaloro on Hemostasis Today.
-
Apr 19, 2026, 10:47Danny Hsu: Unlocking the Real-World Potential of DOACs in Paediatric Thrombosis
-
Apr 19, 2026, 10:39Purusotham Chippala: Demystifying the Research Process in Physiotherapy after Stroke
-
Apr 19, 2026, 10:23Leo Nicolai: Expanding Role of Platelets in Inflammation
-
Apr 19, 2026, 10:18Nishith Patel: PhD or Masters Opportunity in Aortic Disease Research at the University of Auckland
-
Apr 19, 2026, 09:49Evolving Perspectives on Gene Therapy in Haemophilia – EAHAD
-
Apr 19, 2026, 09:35Abdul Mannan: Recognition and Management of Febrile Non-Haemolytic Transfusion Reactions in Clinical Practice
-
Apr 19, 2026, 09:20David McIntosh: The Evolving Safety Framework for Plasma-Derived Therapies
-
Apr 19, 2026, 08:48Mike Thompson: Breaking Down the C-TRACT Trial on Endovascular Therapy for Post-Thrombotic Syndrome
-
Apr 19, 2026, 08:33Mohamed Elgayar։ Not Every Elevated Troponin in a Child Is Myocarditis